Skip to main content

Table 1 Subjects characteristics

From: Modulation of atypical brain activation during executive functioning in autism: a pharmacological MRI study of tianeptine

  ASD (n = 19) TD (n = 19) t-test p value
Age 30 ± 11 (19–50) 27 ± 9 (19–52) 0.3
IQ 113 ± 14 (79–139) 115 ± 10 (88–130) 0.7
ADI-R—Communication 17 ± 9  
ADI-R—Social Interaction 14 ± 8  
ADI-R—Repetitive Behaviour 5 ± 2  
ADOS—Communication 3 ± 2  
ADOS—Social Interaction 6 ± 2  
AQ 31 ± 11 12 ± 7  < 0.001***
HAM-D 6 ± 4 2 ± 3 0.001**
HAM-A 8 ± 6 3 ± 4 0.003**
OCI-R 23 ± 13 8 ± 9  < 0.001***
GAD-7 7 ± 5 3 ± 3 0.01*
Barkley Inattention Childhood Self 3.3 ± 3.0 0.7 ± 1.2 0.002**
Barkley Hyperactivity Childhood Self 3.7 ± 2.9 1.1 ± 1.9 0.004**
Barkley Inattention Currently Self 1.4 ± 1.8 0.7 ± 1.5 0.2
Barkley Hyperactivity Currently Self 1.2 ± 1.3 0.4 ± 0.8 0.004**
  1. Data in table are shown as mean ± standard deviation (range) (n = number of participants). n = 19 for sustained attention task and n = 17 for Go/No-Go task, which did not significantly affect between-group differences in baseline characteristics or visual analogue scale measures
  2. TD typically developed controls, ASD individuals with autism spectrum disorder, ADOS Autism Diagnostic Observation Scale, ADI-R Autism Diagnostic Interview-Revised, AQ Autism Quotient, HAM-D Hamilton Depression Rating Scale, HAM-A Hamilton Anxiety Rating Scale, OCI-R Obsessive–Compulsive Inventory Revised, GAD-7 Generalized Anxiety Disorder Assessment
  3. Between group t-test: *p < 0.05; **p < 0.01; ***p < 0.001